Prognostic factors of small cell lung cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Hematology/Oncology Clinics of North America

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.HOC.2003.12.011PMID 15094181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.

  2003cited by this paper
• The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

  2003cited by this paper
• Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens

  2002cited by this paper
• The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033

  2002cited by this paper
• Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?

  2002cited by this paper
• The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.

  2001cited by this paper
• Cytokeratin-derived markersof lung cancer

  2001cited by this paper
• The new World Health Organization classification of lung tumours

  2001cited by this paper
• Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

  2001cited by this paper
• Quality of life in lung cancer patients.

  2001cited by this paper
• Quality of life in lung cancer patients: as an important prognostic factor.

  2001cited by this paper
• Cytokeratin-derived markers of lung cancer.

  2001cited by this paper
• Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance.

  2001cited by this paper
• Prognostic significance of blood coagulation tests in lung cancer.

  2001cited by this paper
• Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.

  2000cited by this paper
• Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies.

  2000cited by this paper
• New chemotherapy agents for small cell lung cancer.

  2000cited by this paper
• Prognostic factors for patients with small cell lung carcinoma

  2000cited by this paper
• Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy.

  2000cited by this paper
• Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.

  2000cited by this paper
• Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer.

  2000cited by this paper
• When is a "prognostic factor" really prognostic?

  2000cited by this paper
• Serum p53 antibodies: predictors of survival in small-cell lung cancer?

  2000cited by this paper
• The epidemiology of lung cancer.

  1999cited by this paper
• Management of small cell lung cancer: current state of the art.

  1999cited by this paper
• Serum copper and zinc content in non-small cell lung cancer: abnormalities and clinical correlates.

  1999cited by this paper
• Serum Pro-Gastrin-Releasing Peptide Is a Useful Marker for Treatment Monitoring and Survival in Small-Cell Lung Cancer

  1999cited by this paper
• Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis

  1999cited by this paper
• Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy.

  1998cited by this paper
• Depressive reactions to lung cancer are common and often followed by a poor outcome.

  1998cited by this paper
• Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma

  1998cited by this paper
• Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials.

  1998cited by this paper
• Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.

  1998cited by this paper
• Molecular abnormalities in lung cancer.

  1998cited by this paper
• Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS.

  1996cited by this paper
• Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer.

  1996cited by this paper
• Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.

  1996cited by this paper
• Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.

  1996cited by this paper
• Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.

  1996cited by this paper
• Clinical applications of serum markers for lung cancer.

  1995cited by this paper
• Prognosis and lung-cancer - the contribution of plasma-proteins.

  1995cited by this paper
• The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer.

  1995cited by this paper
• Prognostic factors in lung cancer: tables and comments.

  1994cited by this paper
• Serum tumour markers in lung cancer: history, biology and clinical applications.

  1994cited by this paper
• Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer

  1993cited by this paper
• Expression of myc family oncoproteins in small‐cell lung‐cancer cell lines and xenografts

  1993cited by this paper
• The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.

  1993cited by this paper
• Prognostic factors in patients with non-small cell lung cancer. A critique of the world literature

  1991cited by this paper
• Soluble interleukin 2 receptor in lung cancer. An indirect marker of tumor activity?

  1991cited by this paper
• Soluble Interleukin 2 Receptor in Lung Cancer: An Indirect Marker of Tumor Activity?

  1991cited by this paper
• Prognostic factors in non-small cell lung cancer: a consensus report

  1991cited by this paper
• Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival.

  1991cited by this paper
• Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.

  1991cited by this paper
• Small-cell carcinoma of the lung: derivation of a prognostic staging system.

  1991cited by this paper
• An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.

  1990cited by this paper
• Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

  1990cited by this paper
• Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.

  1990cited by this paper
• The clinical significance of variant-morphology small-cell carcinoma of the lung.

  1990cited by this paper
• Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma.

  1990cited by this paper
• Staging and prognostic factors in small cell lung cancer: a consensus report

  1989cited by this paper
• Clinical relevance of histologic subtyping in small cell lung cancer

  1989cited by this paper
• Histopathologic classification of small cell lung cancer changing concepts and terminology

  1988cited by this paper
• Prognostic value of pretreatment carcinoembryonic antigen, neuron‐specific enolase, and creatine kinase‐BB levels in sera of patients with small cell lung cancer

  1988cited by this paper
• Increased expression of N-myc in human small cell lung cancer biopsies predicts lack of response to chemotherapy and poor prognosis.

  1987cited by this paper
• myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

  1987cited by this paper
• Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients

  1987cited by this paper
• [Prognostic factors in nonresected adenocarcinoma of the lung].

  1987cited by this paper
• Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging.

  1987cited by this paper
• Morphologic variations of small cell lung cancer: A histopathologic study of pretreatment and posttreatment specimens in 104 patients

  1986cited by this paper
• Performance status assessment among oncology patients: a review.

  1986cited by this paper
• Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.

  1985cited by this paper
• The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the world health organization. A study of 375 consecutive patients

  1983cited by this paper
• Staging and prognostic factors in small cell carcinoma of the lung.

  1983cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer.

  1981cited by this paper
• International Histological Classification of Tumours

  1981cited by this paper
• Prognostic factors for survival in patients with inoperable lung cancer.

  1980cited by this paper
• Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.

  1979cited by this paper
• Lung Cancer: Clinical Diagnosis and Treatment

  1978cited by this paper
• Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.

  1976cited by this paper
• Bronchial Carcinoma

  1960cited by this paper
• Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide

  1960cited by this paper
• The clinical evaluation of chemotherapeutic agents in cancer

  1949cited by this paper
• Evaluation of chemotherapeutic agents

  1949cited by this paper
• The New World Health Organization

  1947cited by this paper

• Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in limited-stage small-cell lung cancer: a meta-analysis.

  2023cites this paper
• Is Onodera's Prognostıc Nutrıtıonal Index (OPNI) a prognostıc factor ın Small Cell Lung Cancer (SCLC)?

  2020cites this paper
• Cancer of the Lung

  2020cites this paper
• The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer

  2019cites this paper
• Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy

  2018cites this paper
• High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer

  2017cites this paper
• [Long-term evolution of a patient diagnosed of small lung cancer with extension to the central nervous system].

  2016cites this paper
• Effects on prognosis of hematologic parameters in patients with small cell lung cancer

  2016cites this paper
• ARAŞTIRMA/RESEARCH Hematolojik parametrelerin küçük hücreli akciğer kanserli hastalarda prognoz üzerine etkileri Effects on prognosis of hematologic parameters in patients with small cell lung cancer

  2016cites this paper
• Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients

  2016cites this paper
• Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Poor Prognosis in Small-cell Lung Cancer.

  2016cites this paper
• Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer

  2015cites this paper
• The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer

  2014cites this paper
• Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer

  2014cites this paper
• Cancer of the Lung: Non–Small Cell Lung Cancer and Small Cell Lung Cancer

  2014cites this paper
• Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung

  2013cites this paper
• Prognostic Factors in Lung Cancer

  2011cites this paper
• Correlation of Apparent Diffusion Coefficient Value With Prognostic Parameters of Lung Cancer

  2011cites this paper
• Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients

  2011cites this paper
• Elevated Serum C-Reactive Protein as a Prognostic Marker in Small Cell Lung Cancer

  2011cites this paper
• Prognostic value of computed tomography morphologic characteristics in stage I non-small-cell lung cancer.

  2010cites this paper
• [Impact of KRAS in standard treatment of non-small cell lung cancer (NSCLC) patients in 2009: prognostic and predictive value].

  2009cites this paper
• A case of small cell carcinoma in the buccal region.

  2009cites this paper
• Small-Cell Lung Cancer: 8 Years Experience of a Single Multidisciplinary Team

  2008cites this paper
• Small cell lung cancer.

  2008cites this paper
• Les facteurs pronostiques

  2008cites this paper
• Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

  2008cites this paper
• The Use of Radiolabeled Somatostatin Analog Scintigraphy in the Staging of Small Cell Lung Cancer Patients

  2007cites this paper
• Management of small cell lung cancer

  2006cites this paper
• Radical Radiotherapy in the Management of Locally Advanced Non-Small-Cell Lung Cancer

  2006cites this paper
• A critical appraisal of prognostic and predictive factors for common lung cancers

  2006cites this paper
• Facteurs pronostiques du cancer bronchique

  2005cites this paper
• A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer

  2005cites this paper
• Management of small-cell lung cancer.

  2004cites this paper
• O Cyfra 21-1 é um determinante prognóstico no carcinoma pulmonar não de pequenas células (CPNPC): resultado de uma meta-análise que incluiu 2063 doentes

  2004cites this paper
• A Subset Analysis from a Randomized Clinical Phase III Trial

  year unknowncites this paper